The histone deacetylase inhibitor romidepsin increases cellular acetyl-methyllysine
Authors:
- Charlie L. BrownCBCharlie L. Brown
- Andreas P. Pintado-UrbancAPAndreas P. Pintado-Urbanc
- Aurora A. MirandaAMAurora A. Miranda
- Yeil KimYKYeil Kim
- Joshua T. YoungJYJoshua T. Young
- Matthew D. SimonMSMatthew D. Simon
Open Access
- 17 November 2026
- journal article
- Published by Elsevier in Journal of Biological Chemistry
Abstract
No abstract availableFunding Information
- National Institute of General Medical Sciences
This publication has 70 references indexed in Scilit:
- Comprehensive mass spectrometry screening-derived atlas of HDAC inhibitors reveals histone-specific acetylation changesCell Reports, 2026
- BRD2 bridges TFIID and MOF-H4K16ac-containing nucleosomes to promote transcriptional initiationMolecular Cell, 2025
- Targeting histone deacetylases for cancer therapy: Trends and challengesActa Pharmaceutica Sinica B, 2023
- Exploring Epigenomic Datasets by ChIPseekerCurrent Protocols, 2022
- HDAC inhibition results in widespread alteration of the histone acetylation landscape and BRD4 targeting to gene bodiesCell Reports, 2021
- Chromatin Accessibility Landscape of Cutaneous T Cell Lymphoma and Dynamic Response to HDAC InhibitorsCancer Cell, 2017
- The BET Protein BRD2 Cooperates with CTCF to Enforce Transcriptional and Architectural BoundariesMolecular Cell, 2017
- Distinct Roles of Brd2 and Brd4 in Potentiating the Transcriptional Program for Th17 Cell DifferentiationMolecular Cell, 2017
- Histone Deacetylases Positively Regulate Transcription through the Elongation MachineryCell Reports, 2015
- The Double Bromodomain Proteins Brd2 and Brd3 Couple Histone Acetylation to TranscriptionMolecular Cell, 2008